J

Joinn Laboratories China Co Ltd
SSE:603127

Watchlist Manager
Joinn Laboratories China Co Ltd
SSE:603127
Watchlist
Price: 17.68 CNY -6.31% Market Closed
Market Cap: 11.1B CNY
Have any thoughts about
Joinn Laboratories China Co Ltd?
Write Note

Joinn Laboratories China Co Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Joinn Laboratories China Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
J
Joinn Laboratories China Co Ltd
SSE:603127
Current Portion of Long-Term Debt
ÂĄ27.9m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Current Portion of Long-Term Debt
ÂĄ263.9m
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Current Portion of Long-Term Debt
ÂĄ449.4m
CAGR 3-Years
64%
CAGR 5-Years
16%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Current Portion of Long-Term Debt
ÂĄ1.1B
CAGR 3-Years
101%
CAGR 5-Years
103%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Current Portion of Long-Term Debt
ÂĄ510.8m
CAGR 3-Years
23%
CAGR 5-Years
71%
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Current Portion of Long-Term Debt
ÂĄ1.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Joinn Laboratories China Co Ltd
Glance View

Market Cap
11.1B CNY
Industry
Life Sciences Tools & Services

Joinn Laboratories China Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 2,140 full-time employees. The company went IPO on 2017-08-25. Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The firm conducts its businesses both in the domestic market and overseas markets.

Intrinsic Value
17.6 CNY
Fairly Valued
Intrinsic Value
Price
J

See Also

What is Joinn Laboratories China Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
27.9m CNY

Based on the financial report for Jun 30, 2024, Joinn Laboratories China Co Ltd's Current Portion of Long-Term Debt amounts to 27.9m CNY.

What is Joinn Laboratories China Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
17%

Over the last year, the Current Portion of Long-Term Debt growth was 3%. The average annual Current Portion of Long-Term Debt growth rates for Joinn Laboratories China Co Ltd have been 17% over the past three years .

Back to Top